Skip to content
Screener
ICU Medical logo

ICU Medical

ICUI

ICU Medical develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care applications.

Market cap
$3.9B+22.3%
Revenue$2.2B-9.0%
Net income$81.2M+187%
Free cash flow$152.8M+121%
EPS (diluted)$3.25+185%
Trailing twelve months · change vs. prior year

Earnings

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$552.1M
EPS estimate$2.13

Financials

Q2 2026

Income statement

See full
Revenue$551.7M+0.5%
Gross profit$235.1M+13.0%
Operating income$39.1M+270%
Net income$19.1M-46.0%
EPS (diluted)$0.76-46.9%

Balance sheet

See full
Cash & equivalents$298.3M-0.6%
Total debt$1.3B-7.1%
Total equity$2.2B+1.7%
Total assets$4.0B-3.3%

Cash flow

See full
Operating cash flow$80.2M+615%
CapEx$18.5M-6.0%
Free cash flow$61.6M

Valuation & ratios

Valuation

See full
Market cap$3.9B+22.3%
Enterprise value$4.91B+13.5%
P/E48×
P/S1.8×+0.4×

Profitability

See full
Gross margin39.1%+3.3pp
Operating margin3.3%+0.4pp
FCF margin7.1%+4.2pp

Returns & leverage

See full
Debt / equity0.6×-0.1×
Current ratio2.4×0.0×

Competitors

Profile

ICU Medical develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care applications. The company provides a comprehensive portfolio of IV pumps, safety software, and consumables designed to enhance patient safety and clinical efficiency in hospital and alternate site settings. Its value proposition centers on being a 'one-stop shop' for integrated infusion systems and critical care products globally.

Competitive position

A leading global provider of integrated infusion therapy systems with a strong emphasis on cybersecurity-certified smart pumps and closed-system transfer devices.

GeographiesUnited States, Costa Rica, Mexico, Czech Republic, India
Customer segmentsAcute Care Hospitals, Ambulatory Surgery Centers, Home Healthcare, Wholesalers
Business modelManufacturing, Direct Sales, Software-as-a-Service, Professional Services
SuppliersRaw material suppliers (plastics, electronics), Contract manufacturers, Single-source component suppliers
CustomersMedical product wholesalers, Independent distributors, Hospital systems, Alternate site healthcare facilities
Listed1992
Employees14.0K
CEOVivek Jain
Websiteicumed.com
FilingsSEC EDGAR

FAQ

What is ICU Medical's market cap?
ICU Medical (ICUI) has a market capitalization of $3.9B and trades on NASDAQ.
What is ICU Medical's revenue and profitability?
ICU Medical generated $2.2B in trailing twelve-month revenue with net income of $81.2M, representing a net margin of -0.3%. Gross margin stands at 39.1%, with free cash flow of $152.8M. The latest reported period is Q2 2026.
Who are ICU Medical's competitors?
ICU Medical's key competitors include Teleflex, Baxter International, AngioDynamics, and others. These companies compete in similar markets and product categories.
Who does ICU Medical partner with?
ICU Medical's notable partners include Otsuka Pharmaceutical Factory America, Inc., Pfizer Inc..
What subsidiaries does ICU Medical have?
ICU Medical's subsidiaries include Smiths Medical, Pursuit Vascular, Inc., Hospira Infusion Systems.
Where is ICU Medical headquartered?
ICU Medical is headquartered in United States of America and employs approximately 14,000 people. It has been publicly traded since 1992.